Carrollton Mother In Murders-Suicide Took Depression Meds

The Carroll County coroner said a woman who police said killed her two young children before taking her own life on Wednesday had been taking medication for depression. Coroner Mandal Haas said Thursday that 24-year-old Madison Hallett hadn’t given any indication that she would kill her children. Police said Hallett first shot and killed her 6-year-old daughter, Natalya Marie Carosiellie, while the girl was in bed. Hallett then went to another bedroom, where police said she shot and killed her 18-month-old son, Drayden W. Hallett-Warnick, while he was sleeping in his crib. Police said Hallett then turned the gun on herself, and her body was found next to her son’s crib.

Confronting Bigots Intolerant of Alternative Mental Health Treatment

A long-term outcome study of schizophrenic patients who were treated with and without psychiatric drugs was published in 2007 in the Journal of Nervous and Mental Disorders. Funded by the National Institute of Mental Health, research psychologist Martin Harrow, at the University of Illinois College of Medicine, discovered that after 4.5 years, 39 percent of the non-medicated group were “in recovery” and 60 percent had jobs. In contrast, during that same time period, the condition of the medicated patients worsened, with only six percent in recovery and few holding jobs. At the fifteen-year follow-up, among the non-drug group, only 28 percent suffered from any psychotic symptoms; in contrast, among the medicated group, 64 were actively psychotic.

Booming Sales of Antipsychotic Drugs Often Fueled by Illegal Marketing Tactics

The Times reports that civil and criminal lawsuits against big pharmaceutical companies have revealed hundreds of documents showing that some company officials knew they were using questionable tactics when they marketed these powerful, expensive drugs. According to analysts and court documents, these tactics have included payments, gifts, meals and trips for doctors, biased studies, and ghostwritten medical journal articles.

Drug Firms Face Bribery Probe from US Department of Justice

Letters from the government to one of the companies, which were reviewed by The Wall Street Journal, identified four types of possible violations: bribing government-employed doctors to purchase drugs; paying company sales agents commissions that are passed along to government doctors; paying hospital committees to approve drug purchases; and paying regulators to win drug approvals.